{
    "nctId": "NCT02550795",
    "briefTitle": "Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer",
    "officialTitle": "Effects of Single Dose Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Postoperative Nausea and Vomiting",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Postoperative Nausea (Numeric Rating Scale for Nausea)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* ASA Physical status I or II female scheduled for breast conserving surgery of modified radical mastectomy.\n\nExclusion Criteria:\n\n* uncontrolled cardiovascular disease\n* history of chronic pain\n* smoker\n* previous history of steroid administraion\n* neoajuvant chemotherapy",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}